April Teitelbaum
Medical Oncology · San Diego, CANPI 1700065463
Payments from drug & device makers
Across 84 payments — averaging $13,427 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Progenics Pharmaceuticals, Inc.$1.1M
- Lantheus Medical Imaging, Inc.$35K
- Puma Biotechnology, Inc.$8K
What the payments were for
- Consulting fees$1,119,59999%
- Travel & lodging$5,8951%
- Food & beverage$7760%
- Education$1,6150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Progenics Pharmaceuticals, Inc. | 76 | $1,084,723 |
| Lantheus Medical Imaging, Inc. | 4 | $35,063 |
| Puma Biotechnology, Inc. | 4 | $8,100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,127,886 in reported general payments places this provider in the 80th percentile of 379 medical oncology providers in California.
Other medical oncology in San Diego
- Marin XavierSan Diego$1.9M
- Sarmad SadeghiLos Angeles$26.1M
- Marwan FakihDuarte$24.2M
- Sumanta PalDuarte$15.9M
- Farshid DayyaniOrange$13.4M
- Daneng LiDuarte$12.4M
- Heinz-Josef LenzLos Angeles$11.6M
- Kevin KimSan Francisco$10.8M
- Anthony El-KhoueiryLos Angeles$10.5M
- Amy ChienSan Francisco$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.